Table 2.
Thirty-six genes regulated by GRβ overexpression in HeLa cells are involved in 43 distinct biologic pathways in KEGG
No. | Gene symbol | Pathways in KEGG | No. | Gene symbol | Pathways in KEGG |
---|---|---|---|---|---|
1 | ABCA3 | hsa02010: ABC transporters—General | 1 | SDHC | hsa00020: Citrate cycle (TCA cycle) |
2 | ACY1 | hsa00220: Urea cycle and metabolism of amino groups | 2 | NDUFA4 | hsa00190: Oxidative phosphorylation |
3 | B2 M | hsa04612: Antigen processing and presentation, | NDUFA5 | ||
4 | BCL2 | hsa01510: Neurodegenerative Diseases | SDHC | ||
hsa04210: Apoptosis | 3 | ACY1 | hsa00220: Urea cycle and metabolism of amino groups | ||
hsa04510: Focal adhesion | MAOA | ||||
hsa05030: Amyotrophic lateral sclerosis (ALS) | 4 | DUT | hsa00240: Pyrimidine metabolism | ||
hsa05060: Prion disease | TYMS | ||||
hsa05210: Colorectal cancer | DTYMK | ||||
hsa05215: Prostate cancer | 5 | GCLC | hsa00251: Glutamate metabolism | ||
hsa05222: Small cell lung cancer | 6 | MAOA | hsa00260: Glycine, serine and threonine metabolism | ||
5 | BRCA1 | hsa04120: Ubiquitin mediated proteolysis | 7 | MAOA | hsa00340: Histidine metabolism |
6 | CANX | hsa04612: Antigen processing and presentation, | 8 | FAH | hsa00350: Tyrosine metabolism |
7 | CCNH | hsa04110: Cell cycle | MAOA | ||
8 | CD9 | hsa04640: Hematopoietic cell lineage | 9 | MAOA | hsa00360: Phenylalanine metabolism |
9 | CDH2 | hsa04514: Cell adhesion molecules (CAMs) | 10 | MAOA | hsa00380: Tryptophan metabolism |
10 | COL4A2 | hsa01430: Cell Communication | 11 | GCLC | hsa00480: Glutathione metabolism |
hsa04510: Focal adhesion | HYAL2 | hsa00531: Glycosaminoglycan degradation | |||
hsa04512: ECM-receptor interaction | FAH | hsa00643: Styrene degradation | |||
hsa05222: Small cell lung cancer | TYMS | hsa00670: One carbon pool by folate | |||
11 | CPE | hsa04940: Type I diabetes mellitus | 12 | HYAL2 | hsa01032: Glycan structures—degradation |
12 | DTYMK | hsa00240: Pyrimidine metabolism, | 13 | COL4A2 | hsa01430: Cell Communication |
13 | DUT | hsa00240: Pyrimidine metabolism | LAMB2 | ||
14 | EFNB1 | hsa04360: Axon guidance | TNC | ||
15 | EPHB2 | hsa04360: Axon guidance | 14 | BCL2 | hsa01510: Neurodegenerative Diseases |
16 | FAH | hsa00350: Tyrosine metabolism | 15 | ABCA3 | hsa02010: ABC transporters—General |
hsa00643: Styrene degradation | 16 | RPL32 | hsa03010: Ribosome | ||
17 | GCLC | hsa00251: Glutamate metabolism | 17 | GTF2A2 | hsa03022: Basal transcription factors |
hsa00480: Glutathione metabolism | 18 | POLB | hsa03030: DNA polymerase | ||
18 | GTF2A2 | hsa03022: Basal transcription factors | 19 | RAP1B | hsa04010: MAPK signaling pathway |
19 | HYAL2 | hsa00531: Glycosaminoglycan degradation | 20 | IL1RAP | hsa04060: Cytokine–cytokine receptor interaction |
hsa01032: Glycan structures—degradation | 21 | CCNH | hsa04110: Cell cycle | ||
20 | IL1RAP | hsa04060: Cytokine–cytokine receptor interaction | 22 | BRCA1 | hsa04120: Ubiquitin mediated proteolysis |
hsa04210: Apoptosis | UBE2D2 | ||||
21 | ITGA3 | hsa04510: Focal adhesion | 23 | BCL2 | hsa04210: Apoptosis |
hsa04512: ECM-receptor interaction | IL1RAP | ||||
hsa04640: Hematopoietic cell lineage | 24 | MMP7 | hsa04310: Wnt signaling pathway | ||
hsa04810: Regulation of actin cytoskeleton | 25 | EFNB1 | hsa04360: Axon guidance | ||
hsa05222: Small cell lung cancer | EPHB2 | ||||
22 | ITGB1 | hsa04360: Axon guidance | ITGB1 | ||
hsa04510: Focal adhesion | 26 | BCL2 | hsa04510: Focal adhesion | ||
hsa04512: ECM-receptor interaction | COL4A2 | ||||
hsa04514: Cell adhesion molecules (CAMs) | ITGA3 | ||||
hsa04670: Leukocyte transendothelial migration | ITGB1 | ||||
hsa04810: Regulation of actin cytoskeleton | LAMB2 | ||||
hsa05130: Pathogenic Escherichia coli infection—EHEC | PPP1R12A | ||||
hsa05131: Pathogenic Escherichia coli infection—EPEC | RAP1B | ||||
hsa05222: Small cell lung cancer | TNC | ||||
23 | LAMB2 | hsa01430: Cell Communication | 27 | COL4A2 | hsa04512: ECM-receptor interaction |
hsa04510: Focal adhesion | ITGA3 | ||||
hsa04512: ECM-receptor interaction | ITGB1 | ||||
hsa05222: Small cell lung cancer | LAMB2 | ||||
24 | MAOA | hsa00220: Urea cycle and metabolism of amino groups | TNC | ||
hsa00260: Glycine, serine and threonine metabolism | 28 | CDH2 | hsa04514: Cell adhesion molecules (CAMs) | ||
hsa00340: Histidine metabolism | ITGB1 | ||||
hsa00350: Tyrosine metabolism | PTPRM | ||||
hsa00360: Phenylalanine metabolism | 29 | PTPRM | hsa04520: Adherens junction | ||
hsa00380: Tryptophan metabolism | 30 | B2M | hsa04612: Antigen processing and presentation, | ||
25 | MMP7 | hsa04310: Wnt signaling pathway | CANX | ||
26 | NDUFA4 | hsa00190: Oxidative phosphorylation | 31 | CD9 | hsa04640: Hematopoietic cell lineage |
27 | NDUFA5 | hsa00190: Oxidative phosphorylation | ITGA3 | ||
28 | POLB | hsa03030: DNA polymerase | 32 | ITGB1 | hsa04670: Leukocyte transendothelial migration |
29 | PPP1R12A | hsa04510: Focal adhesion | RAP1B | ||
hsa04720: Long-term potentiation | 33 | PPP1R12A | hsa04720: Long-term potentiation | ||
hsa04810: Regulation of actin cytoskeleton | RAP1B | ||||
30 | PTPRM | hsa04514: Cell adhesion molecules (CAMs) | 34 | ITGA3 | hsa04810: Regulation of actin cytoskeleton |
hsa04520: Adherens junction | ITGB1 | ||||
31 | RAP1B | hsa04010: MAPK signaling pathway | PPP1R12A | ||
hsa04510: Focal adhesion | 35 | CPE | hsa04940: Type I diabetes mellitus | ||
hsa04670: Leukocyte transendothelial migration | 36 | BCL2 | hsa05030: Amyotrophic lateral sclerosis (ALS) | ||
hsa04720: Long-term potentiation | 37 | BCL2 | hsa05060: Prion disease | ||
hsa05211: Renal cell carcinoma | 38 | ITGB1 | hsa05130: Pathogenic Escherichia coli infection—EHEC | ||
32 | RPL32 | hsa03010: Ribosome | 39 | ITGB1 | hsa05131: Pathogenic Escherichia coli infection—EPEC |
33 | SDHC | hsa00020: Citrate cycle (TCA cycle) | 40 | BCL2 | hsa05210: Colorectal cancer |
hsa00190: Oxidative phosphorylation | 41 | RAP1B | hsa05211: Renal cell carcinoma | ||
34 | TNC | hsa01430: Cell Communication | 42 | BCL2 | hsa05215: Prostate cancer |
hsa04510: Focal adhesion | 43 | BCL2 | hsa05222: Small cell lung cancer | ||
hsa04512: ECM-receptor interaction | COL4A2 | ||||
35 | TYMS | hsa00240: Pyrimidine metabolism | ITGA3 | ||
hsa00670: One carbon pool by folate | ITGB1 | ||||
36 | UBE2D2 | hsa04120: Ubiquitin mediated proteolysis | LAMB2 |